| Reaction Details |
|---|
 | Report a problem with these data |
| Target | OTU domain-containing protein 1 |
|---|
| Ligand | BDBM50538571 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_1973178 (CHEMBL4605996) |
|---|
| IC50 | >10000±n/a nM |
|---|
| Citation |  Leger, PR; Hu, DX; Biannic, B; Bui, M; Han, X; Karbarz, E; Maung, J; Okano, A; Osipov, M; Shibuya, GM; Young, K; Higgs, C; Abraham, B; Bradford, D; Cho, C; Colas, C; Jacobson, S; Ohol, YM; Pookot, D; Rana, P; Sanchez, J; Shah, N; Sun, M; Wong, S; Brockstedt, DG; Kassner, PD; Schwarz, JB; Wustrow, DJ Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity. J Med Chem63:5398-5420 (2020) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| OTU domain-containing protein 1 |
|---|
| Name: | OTU domain-containing protein 1 |
|---|
| Synonyms: | 3.4.19.12 | DUBA-7 | DUBA7 | OTDC1 | OTU domain-containing protein 1 | OTUD1 | OTUD1_HUMAN |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 51057.65 |
|---|
| Organism: | Homo sapiens |
|---|
| Description: | ChEMBL_119925 |
|---|
| Residue: | 481 |
|---|
| Sequence: | MQLYSSVCTHYPAGAPGPTAAAPAPPAAATPFKVSLQPPGAAGAAPEPETGECQPAAAAE
HREAAAVPAAKMPAFSSCFEVVSGAAAPASAAAGPPGASCKPPLPPHYTSTAQITVRALG
ADRLLLHGPDPVPGAAGSAAAPRGRCLLLAPAPAAPVPPRRGSSAWLLEELLRPDCPEPA
GLDATREGPDRNFRLSEHRQALAAAKHRGPAATPGSPDPGPGPWGEEHLAERGPRGWERG
GDRCDAPGGDAARRPDPEAEAPPAGSIEAAPSSAAEPVIVSRSDPRDEKLALYLAEVEKQ
DKYLRQRNKYRFHIIPDGNCLYRAVSKTVYGDQSLHRELREQTVHYIADHLDHFSPLIEG
DVGEFIIAAAQDGAWAGYPELLAMGQMLNVNIHLTTGGRLESPTVSTMIHYLGPEDSLRP
SIWLSWLSNGHYDAVFDHSYPNPEYDNWCKQTQVQRKRDEELAKSMAISLSKMYIEQNAC
S
|
|
|
|---|
| BDBM50538571 |
|---|
| n/a |
|---|
| Name | BDBM50538571 |
|---|
| Synonyms: | CHEMBL4635160 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C28H30ClN3O3S |
|---|
| Mol. Mass. | 524.074 |
|---|
| SMILES | C[C@H]1CNCC[C@H]1Oc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)C4C(C3=O)C4(C)C)sc12 |r| |
|---|
| Structure | 
|
|---|
Search and Browse
